Cargando…
Landscape of Cardiovascular Device Registries in the United States
BACKGROUND: Regulators increasingly rely on registries for decision making related to high‐risk medical devices in the United States. However, the limited uniform standards for registries may create substantial variability in registry implementation and utility to regulators. We surveyed the current...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585371/ https://www.ncbi.nlm.nih.gov/pubmed/31433706 http://dx.doi.org/10.1161/JAHA.119.012756 |
_version_ | 1783428696273584128 |
---|---|
author | Rajan, Prashant V. Holtzman, Jessica N. Kesselheim, Aaron S. Yeh, Robert W. Kramer, Daniel B. |
author_facet | Rajan, Prashant V. Holtzman, Jessica N. Kesselheim, Aaron S. Yeh, Robert W. Kramer, Daniel B. |
author_sort | Rajan, Prashant V. |
collection | PubMed |
description | BACKGROUND: Regulators increasingly rely on registries for decision making related to high‐risk medical devices in the United States. However, the limited uniform standards for registries may create substantial variability in registry implementation and utility to regulators. We surveyed the current landscape of US cardiovascular device registries and chart the extent of inconsistency in goals, administration, enrollment procedures, and approach to data access. METHODS AND RESULTS: A systematic review using Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) guidelines identified studies (1995–2017) referencing cardiovascular device registries with a US‐based institution. Registries were then evaluated by reviewing associated articles and websites. Extracted data included device type, primary scientific aim(s), funding, stewardship (eg, administration of registry procedures), enrollment procedures, informed consent process, and mechanisms to access data for research. The 138 cardiovascular device registries in the cohort covered devices addressing interventional cardiology (65.9%), arrhythmias (15.2%), heart failure (10.1%), and valvular disease (10.1%). While the majority (55.8%) were industry‐funded, stewardship was predominantly overseen by academic centers (74.0%). Most registry participation was voluntary (77.5%), but a substantial minority (19.7%) were required as a condition of device implantation. Informed consent requirements varied widely, with written consent required in only 55.1% of registries. Registry data were primarily accessible only to stewards (84.1%), with 13.8% providing pathways for external applications. CONCLUSIONS: The majority of cardiovascular device registries were funded privately under the auspices of academic institutions, which set the rules for data access. The substantial variation between cardiovascular device registries suggests a role for regulators to further strengthen guidelines to improve quality, consistency, and ethical standards. |
format | Online Article Text |
id | pubmed-6585371 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65853712019-06-27 Landscape of Cardiovascular Device Registries in the United States Rajan, Prashant V. Holtzman, Jessica N. Kesselheim, Aaron S. Yeh, Robert W. Kramer, Daniel B. J Am Heart Assoc Original Research BACKGROUND: Regulators increasingly rely on registries for decision making related to high‐risk medical devices in the United States. However, the limited uniform standards for registries may create substantial variability in registry implementation and utility to regulators. We surveyed the current landscape of US cardiovascular device registries and chart the extent of inconsistency in goals, administration, enrollment procedures, and approach to data access. METHODS AND RESULTS: A systematic review using Preferred Reporting Items for Systematic Reviews and Meta‐Analysis (PRISMA) guidelines identified studies (1995–2017) referencing cardiovascular device registries with a US‐based institution. Registries were then evaluated by reviewing associated articles and websites. Extracted data included device type, primary scientific aim(s), funding, stewardship (eg, administration of registry procedures), enrollment procedures, informed consent process, and mechanisms to access data for research. The 138 cardiovascular device registries in the cohort covered devices addressing interventional cardiology (65.9%), arrhythmias (15.2%), heart failure (10.1%), and valvular disease (10.1%). While the majority (55.8%) were industry‐funded, stewardship was predominantly overseen by academic centers (74.0%). Most registry participation was voluntary (77.5%), but a substantial minority (19.7%) were required as a condition of device implantation. Informed consent requirements varied widely, with written consent required in only 55.1% of registries. Registry data were primarily accessible only to stewards (84.1%), with 13.8% providing pathways for external applications. CONCLUSIONS: The majority of cardiovascular device registries were funded privately under the auspices of academic institutions, which set the rules for data access. The substantial variation between cardiovascular device registries suggests a role for regulators to further strengthen guidelines to improve quality, consistency, and ethical standards. John Wiley and Sons Inc. 2019-06-01 /pmc/articles/PMC6585371/ /pubmed/31433706 http://dx.doi.org/10.1161/JAHA.119.012756 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Rajan, Prashant V. Holtzman, Jessica N. Kesselheim, Aaron S. Yeh, Robert W. Kramer, Daniel B. Landscape of Cardiovascular Device Registries in the United States |
title | Landscape of Cardiovascular Device Registries in the United States |
title_full | Landscape of Cardiovascular Device Registries in the United States |
title_fullStr | Landscape of Cardiovascular Device Registries in the United States |
title_full_unstemmed | Landscape of Cardiovascular Device Registries in the United States |
title_short | Landscape of Cardiovascular Device Registries in the United States |
title_sort | landscape of cardiovascular device registries in the united states |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585371/ https://www.ncbi.nlm.nih.gov/pubmed/31433706 http://dx.doi.org/10.1161/JAHA.119.012756 |
work_keys_str_mv | AT rajanprashantv landscapeofcardiovasculardeviceregistriesintheunitedstates AT holtzmanjessican landscapeofcardiovasculardeviceregistriesintheunitedstates AT kesselheimaarons landscapeofcardiovasculardeviceregistriesintheunitedstates AT yehrobertw landscapeofcardiovasculardeviceregistriesintheunitedstates AT kramerdanielb landscapeofcardiovasculardeviceregistriesintheunitedstates |